Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenomics: Identification of New Drug Targets
The Retinoblastoma Gene
The Retinoblastoma Gene
Ribosome Profiling
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 8, 2026

Quantitative Analysis of Dietary Vitamin A Metabolites in Murine Ocular and Non-Ocular Tissues Using High-Performance Liquid Chromatography
Published on: December 27, 2024
Yan Ma1, Qing Feng, Ian Pitha-Rowe
1Department of Pharmacology and Toxicology, Dartmouth Medical School, Hanover, NH, USA.
This study explores mRNA expression profiling to identify new cancer drug targets. It highlights how retinoids impact tumor cell differentiation and growth, emphasizing protein stability in cancer therapy.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: